Recent Quotes

Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The company's product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The company is also evaluating its investigational drug candidate EVO100 vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-03
REV		(EXPECTED)2021-08-03

Q1 2021		Est.		Actual		Surprise
EPS		-0.490		-0.560		-0.0700
REV		1.630M		1.105M		-530.000K

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
EVFM	Evofem Biosciences	1.18	-0.01	-1.26%		179.6M

Evofem Biosciences Frequently Asked Questions

How do I buy Evofem Biosciences (EVFM) stock?

You can purchase shares of Evofem Biosciences (NASDAQ: EVFM) through any online brokerage.

View our list of the best stock brokerages.

Who are Evofem Biosciences's (EVFM) competitors?

Other companies in Evofem Biosciences’s space includes: Xeris Pharmaceuticals (NASDAQ:XERS), Satsuma Pharmaceuticals (NASDAQ:STSA), SCYNEXIS (NASDAQ:SCYX), Jaguar Health (NASDAQ:JAGX) and Tricida (NASDAQ:TCDA).

What is the target price for Evofem Biosciences (EVFM) stock?

The latest price target for Evofem Biosciences (NASDAQ: EVFM) was reported by HC Wainwright & Co. on June 7, 2021. The analyst firm set a price target for 4.00 expecting EVFM to rise to within 12 months (a possible 240.43% upside). 4 analyst firms have reported ratings in the last year.

Current Stock Price for Evofem Biosciences (EVFM)?

The stock price for Evofem Biosciences (NASDAQ: EVFM) is $1.175 last updated Today at 6:56:38 PM.

Does Evofem Biosciences (EVFM) pay a dividend?

There are no upcoming dividends for Evofem Biosciences.

When is Evofem Biosciences (NASDAQ:EVFM) reporting earnings?

Evofem Biosciences’s Q2 earnings are confirmed for after-market on August 3, 2021.

Is Evofem Biosciences (EVFM) going to split?

There is no upcoming split for Evofem Biosciences.

What sector and industry does Evofem Biosciences (EVFM) operate in?

Evofem Biosciences is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.